American Century Companies’s Achillion Pharmaceuticals ACHN Stock Holding History

American Century Companies’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-48,821	Closed	-$131K	–	1383
2019 Q2	$131K	Buy	+48,821	New	+$144K	﹤0.01%	1246
2016 Q4	–	Sell	-908,673	Closed	-$7.36M	–	1446
2016 Q3	$7.36M	Buy	908,673 +38,380	+4%	+$326K	0.01%	739
2016 Q2	$6.79M	Buy	870,293 +58,521	+7%	+$502K	0.01%	751
2016 Q1	$6.27M	Buy	811,772 +142,854	+21%	+$1.05M	0.01%	767
2015 Q4	$7.22M	Buy	+668,918	New	+$6.08M	0.01%	719
2013 Q3	–	Sell	-91,130	Closed	-$751K	–	1529
2013 Q2	$751K	Buy	+91,130	New	+$696K	﹤0.01%	1261

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

American Century Companies's ACHN Position: Q3 2019 in Review

American Century Companies sold out of Achillion Pharmaceuticals (ACHN) in Q3 2019, closing a stake of 48,821 shares — an estimated $131K sold.

American Century Companies first reported a position in ACHN in Q2 2013 and held it in 6 quarters. The position peaked at $7.36M in Q3 2016. 122 funds tracked by Wall St. Rank hold ACHN as of Q3 2019.

American Century Companies reported no remaining Achillion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
American Century Companies sold 48,821 Achillion Pharmaceuticals shares in Q3 2019, an estimated $131K.
American Century Companies first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
American Century Companies's Achillion Pharmaceuticals position peaked at $7.36M in Q3 2016.
122 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2019.

Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.